Pavel Kopach, MD

Assistant Professor, Pathology

Pavel Kopach


  • Belarusian State Medical University, MD


  • Published on 12/16/2022

    Luzina IG, Lockatell V, Courneya JP, Mei Z, Fishelevich R, Kopach P, Pickering EM, Kang PH, Krupnick AS, Todd NW, Vogel SN, Atamas SP. Full-length IL-33 augments pulmonary fibrosis in an ST2- and Th2-independent, non-transcriptomic fashion. Cell Immunol. 2023 Jan; 383:104657. PMID: 36603504.

    Read at: PubMed
  • Published on 9/2/2020

    Luzina IG, Fishelevich R, Hampton BS, Courneya JP, Parisella FR, Lugkey KN, Baleno FX, Choi D, Kopach P, Lockatell V, Todd NW, Atamas SP. Full-length IL-33 regulates Smad3 phosphorylation and gene transcription in a distinctive AP2-dependent manner. Cell Immunol. 2020 11; 357:104203. PMID: 32977155.

    Read at: PubMed
  • Published on 8/1/2020

    Connell B, Kopach P, Ren W, Joshi R, Naber S, Zhou M, Mathew P. Aberrant integrin av and a5 expression in prostate adenocarcinomas and bone-metastases is consistent with a bone-colonizing phenotype. Transl Androl Urol. 2020 Aug; 9(4):1630-1638. PMID: 32944524.

    Read at: PubMed
  • Published on 11/15/2016

    Kopach P, Genega EM, Shah SN, Kim JJ, Suarez Y. The significance of histologic examination of gastrectomy specimens: a clinicopathologic study of 511 cases. Surg Obes Relat Dis. 2017 Mar; 13(3):463-467. PMID: 28089436.

    Read at: PubMed
  • Published on 3/18/2016

    Luzina IG, Lockatell V, Hyun SW, Kopach P, Kang PH, Noor Z, Liu A, Lillehoj EP, Lee C, Miranda-Ribera A, Todd NW, Goldblum SE, Atamas SP. Elevated expression of NEU1 sialidase in idiopathic pulmonary fibrosis provokes pulmonary collagen deposition, lymphocytosis, and fibrosis. Am J Physiol Lung Cell Mol Physiol. 2016 05 15; 310(10):L940-54. PMID: 26993524.

    Read at: PubMed
  • Published on 7/24/2015

    Luzina IG, Lockatell V, Todd NW, Kopach P, Pentikis HS, Atamas SP. Pharmacological In Vivo Inhibition of S-Nitrosoglutathione Reductase Attenuates Bleomycin-Induced Inflammation and Fibrosis. J Pharmacol Exp Ther. 2015 Oct; 355(1):13-22. PMID: 26209236.

    Read at: PubMed
  • Published on 3/11/2014

    Kopach P, Lockatell V, Pickering EM, Haskell RE, Anderson RD, Hasday JD, Todd NW, Luzina IG, Atamas SP. IFN-? directly controls IL-33 protein level through a STAT1- and LMP2-dependent mechanism. J Biol Chem. 2014 Apr 25; 289(17):11829-11843. PMID: 24619410.

    Read at: PubMed
  • Published on 12/1/2013

    Luzina IG, Kopach P, Lockatell V, Kang PH, Nagarsekar A, Burke AP, Hasday JD, Todd NW, Atamas SP. Interleukin-33 potentiates bleomycin-induced lung injury. Am J Respir Cell Mol Biol. 2013 Dec; 49(6):999-1008. PMID: 23837438.

    Read at: PubMed
  • Published on 5/25/2012

    Luzina IG, Pickering EM, Kopach P, Kang PH, Lockatell V, Todd NW, Papadimitriou JC, McKenzie AN, Atamas SP. Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion. J Immunol. 2012 Jul 01; 189(1):403-10. PMID: 22634619.

    Read at: PubMed

View all profiles